Concord Drugs Limited, founded in 1995, is a leading pharmaceutical company in India. Specializing in generics, branded, and specialty pharmaceuticals, Concord is known for its diverse product portfolio of over 200 prescription and over-the-counter products.

Concord Drugs major competitors are Bacil Pharma, Lasa Supergenerics, Medicamen Organics, Kabra Drugs, Godavari Drugs, Shanmuga Hospital, Deccan Health Care.
Market Cap of Concord Drugs is ₹56 Crs.
While the median market cap of its peers are ₹51 Crs.

Concord Drugs seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.